1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Davis, Ian D

Results 21-40 of 45 (Search time: 0.017 seconds).

Publication YearTitleAuthor(s)
2115-Apr-2008The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.Ebert, Lisa M; Tan, Bee Shin; Browning, Judy; Svobodova, Suzanne; Russell, Sarah E; Kirkpatrick, Naomi; Gedye, Craig; Moss, Denis; Ng, Sweet Ping ; MacGregor, Duncan; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
221-Dec-2007Immunotherapy of advanced or metastatic melanoma.Cebon, Jonathan S ; Gedye, Craig; John, Thomas ; Davis, Ian D
2315-Jun-2007An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.Davis, Ian D; Skrumsager, Birte K; Cebon, Jonathan S ; Nicholaou, Theo; Barlow, John W; Moller, Niels Peter Hundahl; Skak, Kresten; Lundsgaard, Dorthe; Frederiksen, Klaus Stensgaard; Thygesen, Peter; McArthur, Grant A
2410-Sep-2006Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.Davis, Ian D; Chen, Qiyuan; Morris, Leone; Quirk, Juliet; Stanley, Maureen; Tavarnesi, Maria L; Parente, Phillip; Cavicchiolo, Tina; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin Yee; MacGregor, Duncan; Browning, Judy; Svobodova, Suzanne; Caron, Dania; Maraskovsky, Eugene; Old, Lloyd J; Chen, Weisan; Cebon, Jonathan S 
251-Aug-2006Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.Lim, Elgene; Browning, Judy; MacGregor, Duncan; Davis, Ian D; Cebon, Jonathan S 
261-Jun-2006Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Nicholaou, Theo; Ebert, Lisa; Davis, Ian D; Robson, Neil; Klein, Oliver ; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S 
2715-May-2006Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.Jackson, Heather M; Dimopoulos, Nektaria; Mifsud, Nicole A; Tai, Tsin Yee; Chen, Qiyuan; Svobodova, Suzanne; Browning, Judy; Luescher, Immanuel F; Stockert, Lisa; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
2819-Nov-2005A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.Gan, Hui K ; Mitchell, Paul L R ; Galettis, Peter; Davis, Ian D; Cebon, Jonathan S ; de Souza, Paul; Links, Matthew
298-Jul-2005Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.Harris, Marion T; Berlangieri, Salvatore U ; Cebon, Jonathan S ; Davis, Ian D; Scott, Andrew M 
3022-Feb-2005Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J
312005Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.Murphy, R; Green, S; Ritter, G; Cohen, L; Ryan, D; Woods, W; Rubira, M; Cebon, Jonathan S ; Davis, Ian D; Sjolander, A; Kypridis, A; Kalnins, Renate M; McNamara, M; Moloney, M B; Ackland, J; Cartwright, Glenn A; Rood, J; Dumsday, G; Healey, K; Maher, D; Maraskovsky, Eugene; Chen, Y T; Hoffman, E W; Old, Lloyd J; Scott, Andrew M 
3216-Nov-2004Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.Schnurr, Max; Chen, Qiyuan; Shin, Amanda; Chen, Weisan; Toy, Tracey; Jenderek, Corinna; Green, Simon; Miloradovic, Lena; Drane, Debbie; Davis, Ian D; Villadangos, Jose; Shortman, Ken; Maraskovsky, Eugene; Cebon, Jonathan S 
3323-Sep-2004The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.Shackleton, Mark; Davis, Ian D; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin; Chen, Qiyuan; Parente, Phillip; Jefford, Michael; Masterman, Kelly-Anne; Caron, Dania; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
341-Aug-2004A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.Jackson, Heather M; Dimopoulos, Nektaria; Chen, Qiyuan; Luke, Tina; Yee Tai, Tsin; Maraskovsky, Eugene; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
3514-Jun-2004Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.Chen, Qiyuan; Jackson, Heather M; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
361-Apr-2004A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer.Mitchell, Paul L R ; Basser, R L; Chipman, M; Grigg, Andrew P ; Mansfield, R; Cebon, Jonathan S ; Davis, Ian D; Appia, F; Green, M
379-Oct-2003Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells.Schnurr, Max; Toy, Tracey; Shin, Amanda; Hartmann, Gunther; Rothenfusser, Simon; Soellner, Julia; Davis, Ian D; Cebon, Jonathan S ; Maraskovsky, Eugene
388-May-2003Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli.Jefford, Michael; Schnurr, Max; Toy, Tracey; Masterman, Kelly-Anne; Shin, Amanda; Beecroft, Tina; Tai, Tsin Yee; Shortman, Ken; Shackleton, Mark; Davis, Ian D; Parente, Phil; Luft, Thomas; Chen, Weisan; Cebon, Jonathan S ; Maraskovsky, Eugene
3920-Mar-2003ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling.Schnurr, Max; Toy, Tracey; Stoitzner, Patrizia; Cameron, Paul; Shin, Amanda; Beecroft, Tina; Davis, Ian D; Cebon, Jonathan S ; Maraskovsky, Eugene
401-Jan-2003Rational approaches to human cancer immunotherapy.Davis, Ian D; Jefford, Michael; Parente, Phillip; Cebon, Jonathan S